Dissecting Yersinia Yop Targets in Neutrophils
解析中性粒细胞中的耶尔森氏菌 Yop 靶标
基本信息
- 批准号:10570181
- 负责人:
- 金额:$ 71.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-11 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AgonistAntibacterial ResponseAtherosclerosisAutoimmune DiseasesBacteriaBiological ModelsCellsChemotaxisCommunicable DiseasesCritical PathwaysCytoplasmic GranulesDependenceDevelopmentDiabetes MellitusDiseaseEventFunctional disorderG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGeneticGoalsGram-Negative Bacterial InfectionsGrowthHematopoietic stem cellsImmuneInfectionInfection ControlIntegrinsKlebsiella InfectionsKlebsiella pneumoniaeLearningLocationLungLung infectionsLupusMAPK3 geneMalignant NeoplasmsMeasuresMediatingMembraneMissense MutationModelingMolecularMulti-Drug ResistanceMultiple Bacterial Drug ResistanceMusMutationMyelogenousPLCgamma2Pasteurella pseudotuberculosisPathway interactionsPhagocytosisPhosphorylationPhosphorylation SitePlayPredispositionProcessProductionProtein Tyrosine KinaseProtein Tyrosine PhosphataseProtein-Serine-Threonine KinasesProteinsReactive Oxygen SpeciesRoleSignal PathwaySignal TransductionSyndromeTestingTherapeuticTimeTissuesVirulenceVisualizationWorkYersiniaantimicrobialbacterial geneticsbactericideextracellulargenetic manipulationin vitro Assayin vivoinsightmigrationmutantneutrophilnovelpathogenpathogenic bacteriaphosphatidylinositol 3-kinase gammapreventprogenitorprotein complexreceptorresponserhoB p20 GDIscaffoldskills
项目摘要
ABSTRACT
Neutrophils (PMNs, polymorphonuclear cells) are pivotal innate immune cells that directly mediate
pathogen clearance through release of reactive oxygen species (ROS), degranulation, neutrophilic
extracellular traps (NETs) and phagocytosis. The bacterial pathogen, Yersinia pseudotuberculosis (Yptb)
antagonizes these antimicrobial actions by injecting critical virulence proteins, called Yops, into PMNs. We
seek to understand mechanisms that mediate clearance of bacterial pathogens in tissue infection by
understanding the processes that are disrupted by YopH and YopO. We have shown that SKAP2 is one
essential target of YopH in PMNs in tissue infection; however, SKAP2 is not the only essential target of YopH
in tissue infection. Missense mutations in SKAP2 are associated with the development of autoimmune
disorders and cancers. This suggests that PMN dysfunction downstream of SKAP2 signaling has wide ranging
implications beyond infection control. We have further shown that SKAP2-dependent mechanisms in
neutrophils are critical for limiting growth of another Gram-negative pathogen, Klebsiella pneumoniae (Kp), in
lungs. Using PMNs derived from myeloid progenitor (MP) hematopoietic stem cells, we found that SKAP2 is
essential for extracellular (ROS) production but is not required for degranulation after Kp infection. Surprisingly,
SKAP2 is required for Syk phosphorylation after infection by Kp, but not for Syk phosphorylation after
stimulation of CLRs and integrin receptors, indicating that neutrophil recognition of Kp is via a distinct receptor,
possibly a G protein coupled receptor (GPCR). The objective of this application is to use our expertise in
murine infection models, MP-PMN genetic manipulation, bacterial genetics and live-cell visualization of protein
complexes, to understand pathways in PMNs that are targeted by YopH and YopO. We will further investigate
whether these targets play crucial roles in the control Kp. To this end, our specific aims are to (1) Dissect the
modular functions of SKAP2 required for generating anti-microbial responses in neutrophils after infection with
Kp. (2) Understand the effects of YopO on GPCR signaling in PMNs during murine infection. (3) Identify the
SKAP2-independent pathways that are targeted by YopH to inactivate neutrophil degranulation. After
completion of these studies, we will understand how SKAP2 and other Yop-targeted proteins work in PMNs to
control infection by Kp and Yptb. A thorough understanding of molecular mechanisms that signal for the
release of the tissue damaging bactericidal factors, ROS and granules, by PMNs during infection should lead
to novel and targeted approaches to manipulate these pathways to enhance these activities during infection
with multidrug resistant bacteria and to stop excessive damage due to uncontrolled PMN responses in a
variety of auto-immune diseases.
摘要
中性粒细胞(PMNs,多形核细胞)是直接介导免疫应答的关键先天性免疫细胞。
通过释放活性氧(ROS)、脱粒、嗜酸性粒细胞
细胞外陷阱(NET)和吞噬作用。假结核耶尔森菌(Yersinia pseudotuberculosis,Yptb)
通过向中性粒细胞注射称为Yops的关键毒力蛋白来拮抗这些抗菌作用。我们
试图了解介导组织感染中细菌病原体清除的机制,
了解被YopH和YopO破坏的过程。我们已经证明SKAP 2是一个
在组织感染中,中性粒细胞中YopH的基本靶标;然而,SKAP 2不是YopH的唯一基本靶标
在组织感染中。SKAP 2的错义突变与自身免疫性疾病的发生相关
疾病和癌症。这表明SKAP 2信号下游的PMN功能障碍具有广泛的
感染控制之外的影响。我们进一步表明,SKAP 2依赖性机制在
嗜中性粒细胞对于限制另一种革兰氏阴性病原体肺炎克雷伯氏菌(Kp)的生长至关重要,
肺使用来自髓系祖细胞(MP)造血干细胞的PMNs,我们发现SKAP 2是
对于细胞外(ROS)产生是必需的,但对于Kp感染后的脱粒不是必需的。令人惊奇的是,
SKAP 2是Kp感染后Syk磷酸化所必需的,但不是感染后Syk磷酸化所必需的。
CLRs和整联蛋白受体的刺激,表明中性粒细胞通过不同的受体识别Kp,
可能是G蛋白偶联受体(GPCR)。本申请的目的是利用我们的专业知识,
小鼠感染模型,MP-PMN遗传操作,细菌遗传学和蛋白质的活细胞可视化
复合物,以了解由YopH和YopO靶向的PMN中的途径。我们将进一步调查
这些目标是否在控制Kp中起关键作用。为此,我们的具体目标是(1)解剖
SKAP 2的模块化功能是在感染后中性粒细胞中产生抗微生物应答所需的
Kp. (2)了解YopO对小鼠感染期间PMN中GPCR信号传导的影响。(3)识别
YopH靶向的SKAP 2-非依赖性途径,以抑制中性粒细胞脱粒。后
完成这些研究后,我们将了解SKAP 2和其他Yop靶向蛋白如何在PMN中发挥作用,
控制Kp和Yptb的感染。深入了解分子机制,信号为
在感染过程中,中性粒细胞释放破坏组织的杀菌因子,ROS和颗粒,
新的和有针对性的方法来操纵这些途径,以增强感染期间的这些活动
与多药耐药细菌,并停止过度损害,由于不受控制的中性粒细胞反应,
各种自身免疫性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan C Mecsas其他文献
Joan C Mecsas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan C Mecsas', 18)}}的其他基金
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
- 批准号:
9222476 - 财政年份:2017
- 资助金额:
$ 71.77万 - 项目类别:
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
- 批准号:
9533472 - 财政年份:2017
- 资助金额:
$ 71.77万 - 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
- 批准号:
9335269 - 财政年份:2016
- 资助金额:
$ 71.77万 - 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
- 批准号:
9046046 - 财政年份:2016
- 资助金额:
$ 71.77万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
8848342 - 财政年份:2014
- 资助金额:
$ 71.77万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
9055639 - 财政年份:2014
- 资助金额:
$ 71.77万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
8764810 - 财政年份:2014
- 资助金额:
$ 71.77万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
9258385 - 财政年份:2014
- 资助金额:
$ 71.77万 - 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
- 批准号:
7839596 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
- 批准号:
7681382 - 财政年份:2008
- 资助金额:
$ 71.77万 - 项目类别:
相似海外基金
Role of the antiviral ribonuclease, RNase-L, in the host antibacterial response
抗病毒核糖核酸酶 RNase-L 在宿主抗菌反应中的作用
- 批准号:
8317571 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:
Role of the antiviral ribonuclease, RNase-L, in the host antibacterial response
抗病毒核糖核酸酶 RNase-L 在宿主抗菌反应中的作用
- 批准号:
7914406 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:
Role of the antiviral ribonuclease, RNase-L, in the host antibacterial response
抗病毒核糖核酸酶 RNase-L 在宿主抗菌反应中的作用
- 批准号:
8224058 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:
Role of the antiviral ribonuclease, RNase-L, in the host antibacterial response
抗病毒核糖核酸酶 RNase-L 在宿主抗菌反应中的作用
- 批准号:
8082155 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:
Role of the antiviral ribonuclease, RNase-L, in the host antibacterial response
抗病毒核糖核酸酶 RNase-L 在宿主抗菌反应中的作用
- 批准号:
7737523 - 财政年份:2009
- 资助金额:
$ 71.77万 - 项目类别:














{{item.name}}会员




